The content on this site is intended for healthcare professionals only
NETTER-1: Targeted radionuclide therapy improves PFS in mid-gut NETs
Prof Philippe Ruszniewski - Paris Diderot University, Paris, France
27 Sep 2015
RADIANT-4: Results of international trial show promise in the treatment of neuro...
Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA
27 Sep 2015
Mid-gut NETs respond to targeted radionuclide therapy: NETTER-1 results
Prof Philippe Ruszniewski - Paris Diderot University, Paris, France
27 Sep 2015
Everolimus for non-functional neuroendocrine tumours
Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA
26 Sep 2015
Highlights of the p-medicine project
2 Sep 2015
The p-medicine project and ECRIN
Jacques Demotes - ECRIN
2 Sep 2015
Investigational ER degrader safe, with early signs of antitumour activity agains...
Dr Maura Dickler - Memorial Sloan Kettering Cancer Center, New York, USA
1 May 2015
New approaches and new partnership models for biomarker based clinical research
Dr Denis Lacombe, EORTC, Brussels, Belgium
6 Jan 2015
Aims and successes of the 2nd EurocanPlatform project translational research cou...
Christina von Gertten, Karolinska Institutet, Stockholm, Sweden
6 Jan 2015
Epigenome deregulation in cancer
Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, Fran...
6 Jan 2015
Immunotherapy of cancer: recent progress and future challenges
Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden
6 Jan 2015
Reasons to attend the EurocanPlatform translational research course 2015
Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany
6 Jan 2015